1. Alamanda VK, Crosby SN, Archer KR et al.: Amputation for extremity soft tissue sarcoma does not increase overall survival: a retrospective cohort study. Eur J Surg Oncol Dec;38(12) (2012) 1178–1183. doi:10.1016/j.ejso.2012.08.024.
2. Amin MB, Edge SB, Greene F et al.: AJCC Cancer Staging Manual, 8th ed. Springer International Publishing, New York (2017).
3. Bitz U, Pink D, Busemann C, Reichardt P: Doxorubicin and dacarbazine as first-line therapy for patients with locally advaned or metastatic leiomyosarcoma and liposarcoma. JCO 29 (2011) (suppl; abstr 10094).
4. Bonvalot S, Rivoire M, Castaing M et al.: Primary retroperitoneal sarcomas: a multivariate analysis of surgical factors associated with local control. J Clin Oncol Jan 1;27(1) (2009) 31–37. doi:10.1200/JCO. 2008.18.0802.
5. Casali PG, Abecassis N, Bauer S et al.: ESMO clinical practice guidelines: Soft tissue and visceral sarcomas: ESMO-EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol 29(4) (2018) iv51–iv67.